» Articles » PMID: 28786975

Neuroimaging Evidence of Brain Abnormalities in Mastocytosis

Overview
Date 2017 Aug 9
PMID 28786975
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Mastocytosis is a rare disease in which chronic symptoms are related to mast cell accumulation and activation. Patients can display depression-anxiety-like symptoms and cognitive impairment. The pathophysiology of these symptoms may be associated with tissular mast cell infiltration, mast cell mediator release or both. The objective of this study is to perform morphological or functional brain analyses in mastocytosis to identify brain changes associated with this mast cell disorder. We performed a prospective and monocentric comparative study to evaluate the link between subjective psycho-cognitive complaints, psychiatric evaluation and objective medical data using magnetic resonance imaging with morphological and perfusion sequences (arterial spin-labeled perfusion) in 39 patients with mastocytosis compared with 33 healthy controls. In the test cohort of 39 mastocytosis patients with psycho-cognitive complaints, we found that 49% of them had morphological brain abnormalities, mainly abnormal punctuated white matter abnormalities (WMA). WMA were equally frequent in cutaneous mastocytosis patients and indolent forms of systemic mastocytosis patients (42% and 41% of patients with WMA, respectively). Patients with WMA showed increased perfusion in the putamen compared with patients without WMA and with healthy controls. Putamen perfusion was also negatively correlated with depression subscores. This study demonstrates, for we believe the first time, a high prevalence of morphological and functional abnormalities in the brains of mastocytosis patients with neuropsychiatric complaints. Further studies are required to determine the mechanism underpinning this association and to ascertain its specificity.

Citing Articles

Cognitive, neuropsychiatric and neurological alterations in mastocytosis: A systematic review.

Sagues-Sese E, Garcia-Casares N, Alvarez-Twose I Clin Transl Allergy. 2023; 13(12):e12319.

PMID: 38146805 PMC: 10718195. DOI: 10.1002/clt2.12319.


Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series.

Weinstock L, Nelson R, Blitshteyn S J Pers Med. 2023; 13(11).

PMID: 38003876 PMC: 10672129. DOI: 10.3390/jpm13111562.


Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID.

Theoharides T, Kempuraj D Cells. 2023; 12(5).

PMID: 36899824 PMC: 10001285. DOI: 10.3390/cells12050688.


Mastocytosis patients' cognitive dysfunctions correlate with the presence of spindle-shaped mast cells in bone marrow.

Spolak-Bobryk N, Romantowski J, Kujawska-Danecka H, Niedoszytko M Clin Transl Allergy. 2022; 12(1):e12093.

PMID: 35035879 PMC: 8752580. DOI: 10.1002/clt2.12093.


Mastocytosis-A Review of Disease Spectrum with Imaging Correlation.

Elsaiey A, Mahmoud H, Jensen C, Klimkowski S, Taher A, Chaudhry H Cancers (Basel). 2021; 13(20).

PMID: 34680251 PMC: 8533777. DOI: 10.3390/cancers13205102.


References
1.
Longley B, Tyrrell L, Lu S, Ma Y, Langley K, Ding T . Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet. 1996; 12(3):312-4. DOI: 10.1038/ng0396-312. View

2.
Capuron L, Pagnoni G, Demetrashvili M, Lawson D, Fornwalt F, Woolwine B . Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology. 2007; 32(11):2384-92. DOI: 10.1038/sj.npp.1301362. View

3.
Akin C, Valent P . Diagnostic criteria and classification of mastocytosis in 2014. Immunol Allergy Clin North Am. 2014; 34(2):207-18. DOI: 10.1016/j.iac.2014.02.003. View

4.
Drevets W, Savitz J, Trimble M . The subgenual anterior cingulate cortex in mood disorders. CNS Spectr. 2008; 13(8):663-81. PMC: 2729429. DOI: 10.1017/s1092852900013754. View

5.
Sacher J, Neumann J, Funfstuck T, Soliman A, Villringer A, Schroeter M . Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. J Affect Disord. 2011; 140(2):142-8. DOI: 10.1016/j.jad.2011.08.001. View